Details
Title
Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Author
Pitt, Jason J 1 ; Riester, Markus 2
; Zheng Yonglan 3
; Yoshimatsu, Toshio F 3
; Sanni Ayodele 4 ; Oluwasola Olayiwola 5 ; Veloso Artur 2 ; Labrot Emma 2 ; Wang Shengfeng 6 ; Odetunde Abayomi 7 ; Adeyinka, Ademola 8 ; Okedere Babajide 7 ; Mahan, Scott 2 ; Leary, Rebecca 2 ; Macomber Maura 2 ; Ajani Mustapha 5 ; Johnson, Ryan S 2 ; Fitzgerald, Dominic 9 ; Jason, Grundstad A 9 ; Tuteja, Jigyasa H 9 ; Khramtsova Galina 3 ; Zhang, Jing 3 ; Sveen, Elisabeth 3 ; Hwang, Bryce 2 ; Clayton, Wendy 3 ; Chibuzor, Nkwodimmah 8 ; Bisola, Famooto 8 ; Obasi Esther 4 ; Aderoju Victor 10 ; Oludara Mobolaji 10 ; Folusho, Omodele 10 ; Akinyele Odunayo 3 ; Adeoye Adewunmi 5 ; Ogundiran Temidayo 8 ; Babalola Chinedum 11 ; MacIsaac Kenzie 2 ; Popoola Abiodun 12 ; Morrissey, Michael P 2 ; Chen, Lin S 13 ; Wang Jiebiao 13 ; Olopade, Christopher O 3 ; Falusi, Adeyinka G 7 ; Winckler, Wendy 2 ; Haase Kerstin 14
; Van Loo Peter 15
; Obafunwa, John 4 ; Papoutsakis Dimitris 2 ; Oladosu, Ojengbede 16 ; Weber, Barbara 2 ; Ibrahim Nasiru 10 ; White, Kevin P 17 ; Huo Dezheng 18 ; Olopade, Olufunmilayo I 19
; Barretina Jordi 20
1 University of Chicago, Institute for Genomics and Systems Biology, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822) ; National University of Singapore, Cancer Science Institute of Singapore, Singapore 117599, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
2 Novartis Institutes for BioMedical Research, Cambridge, USA (GRID:grid.418424.f) (ISNI:0000 0004 0439 2056)
3 University of Chicago, Center for Clinical Cancer Genetics & Global Health, Department of Medicine, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
4 Lagos State University Teaching Hospital, Department of Pathology and Forensic Medicine, Ikeja, Nigeria (GRID:grid.411278.9) (ISNI:0000 0004 0481 2583)
5 University of Ibadan, Department of Pathology, Ibadan, Nigeria (GRID:grid.9582.6) (ISNI:0000 0004 1794 5983)
6 University of Chicago, Center for Clinical Cancer Genetics & Global Health, Department of Medicine, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822) ; Peking University Health Science Center, Department of Epidemiology and Biostatistics, School of Public Health, Beijing 100191, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)
7 University of Ibadan, Institute for Advanced Medical Research and Training, College of Medicine, Ibadan, Nigeria (GRID:grid.9582.6) (ISNI:0000 0004 1794 5983)
8 University of Ibadan, Department of Surgery, Ibadan, Nigeria (GRID:grid.9582.6) (ISNI:0000 0004 1794 5983)
9 University of Chicago, Institute for Genomics and Systems Biology, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
10 Lagos State University Teaching Hospital, Department of Surgery, Ikeja, Nigeria (GRID:grid.411278.9) (ISNI:0000 0004 0481 2583)
11 University of Ibadan, Institute for Advanced Medical Research and Training, College of Medicine, Ibadan, Nigeria (GRID:grid.9582.6) (ISNI:0000 0004 1794 5983) ; University of Ibadan, Department of Pharmaceutical Chemistry, Ibadan, Nigeria (GRID:grid.9582.6) (ISNI:0000 0004 1794 5983)
12 Lagos State University, Oncology Unit, Department of Radiology, Ikeja, Nigeria (GRID:grid.411276.7) (ISNI:0000 0001 0725 8811)
13 University of Chicago, Department of Public Health Sciences, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
14 The Francis Crick Institute, London NW1 1AT, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830)
15 The Francis Crick Institute, London NW1 1AT, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830) ; University of Leuven, Department of Human Genetics, Leuven 3000, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884)
16 University of Ibadan, Centre for Population and Reproductive Health, College of Medicine, Ibadan, Nigeria (GRID:grid.9582.6) (ISNI:0000 0004 1794 5983)
17 University of Chicago, Institute for Genomics and Systems Biology, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822) ; Tempus Labs, Inc., Chicago, USA (GRID:grid.170205.1)
18 University of Chicago, Center for Clinical Cancer Genetics & Global Health, Department of Medicine, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822) ; University of Chicago, Department of Public Health Sciences, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
19 University of Chicago, Institute for Genomics and Systems Biology, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822) ; University of Chicago, Center for Clinical Cancer Genetics & Global Health, Department of Medicine, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
20 Novartis Institutes for BioMedical Research, Cambridge, USA (GRID:grid.418424.f) (ISNI:0000 0004 0439 2056) ; Girona Biomedical Research Institute (IDIBGI), Girona 17007, Spain (GRID:grid.429182.4)
; Zheng Yonglan 3
; Yoshimatsu, Toshio F 3
; Sanni Ayodele 4 ; Oluwasola Olayiwola 5 ; Veloso Artur 2 ; Labrot Emma 2 ; Wang Shengfeng 6 ; Odetunde Abayomi 7 ; Adeyinka, Ademola 8 ; Okedere Babajide 7 ; Mahan, Scott 2 ; Leary, Rebecca 2 ; Macomber Maura 2 ; Ajani Mustapha 5 ; Johnson, Ryan S 2 ; Fitzgerald, Dominic 9 ; Jason, Grundstad A 9 ; Tuteja, Jigyasa H 9 ; Khramtsova Galina 3 ; Zhang, Jing 3 ; Sveen, Elisabeth 3 ; Hwang, Bryce 2 ; Clayton, Wendy 3 ; Chibuzor, Nkwodimmah 8 ; Bisola, Famooto 8 ; Obasi Esther 4 ; Aderoju Victor 10 ; Oludara Mobolaji 10 ; Folusho, Omodele 10 ; Akinyele Odunayo 3 ; Adeoye Adewunmi 5 ; Ogundiran Temidayo 8 ; Babalola Chinedum 11 ; MacIsaac Kenzie 2 ; Popoola Abiodun 12 ; Morrissey, Michael P 2 ; Chen, Lin S 13 ; Wang Jiebiao 13 ; Olopade, Christopher O 3 ; Falusi, Adeyinka G 7 ; Winckler, Wendy 2 ; Haase Kerstin 14
; Van Loo Peter 15
; Obafunwa, John 4 ; Papoutsakis Dimitris 2 ; Oladosu, Ojengbede 16 ; Weber, Barbara 2 ; Ibrahim Nasiru 10 ; White, Kevin P 17 ; Huo Dezheng 18 ; Olopade, Olufunmilayo I 19
; Barretina Jordi 20
1 University of Chicago, Institute for Genomics and Systems Biology, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822) ; National University of Singapore, Cancer Science Institute of Singapore, Singapore 117599, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
2 Novartis Institutes for BioMedical Research, Cambridge, USA (GRID:grid.418424.f) (ISNI:0000 0004 0439 2056)
3 University of Chicago, Center for Clinical Cancer Genetics & Global Health, Department of Medicine, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
4 Lagos State University Teaching Hospital, Department of Pathology and Forensic Medicine, Ikeja, Nigeria (GRID:grid.411278.9) (ISNI:0000 0004 0481 2583)
5 University of Ibadan, Department of Pathology, Ibadan, Nigeria (GRID:grid.9582.6) (ISNI:0000 0004 1794 5983)
6 University of Chicago, Center for Clinical Cancer Genetics & Global Health, Department of Medicine, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822) ; Peking University Health Science Center, Department of Epidemiology and Biostatistics, School of Public Health, Beijing 100191, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)
7 University of Ibadan, Institute for Advanced Medical Research and Training, College of Medicine, Ibadan, Nigeria (GRID:grid.9582.6) (ISNI:0000 0004 1794 5983)
8 University of Ibadan, Department of Surgery, Ibadan, Nigeria (GRID:grid.9582.6) (ISNI:0000 0004 1794 5983)
9 University of Chicago, Institute for Genomics and Systems Biology, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
10 Lagos State University Teaching Hospital, Department of Surgery, Ikeja, Nigeria (GRID:grid.411278.9) (ISNI:0000 0004 0481 2583)
11 University of Ibadan, Institute for Advanced Medical Research and Training, College of Medicine, Ibadan, Nigeria (GRID:grid.9582.6) (ISNI:0000 0004 1794 5983) ; University of Ibadan, Department of Pharmaceutical Chemistry, Ibadan, Nigeria (GRID:grid.9582.6) (ISNI:0000 0004 1794 5983)
12 Lagos State University, Oncology Unit, Department of Radiology, Ikeja, Nigeria (GRID:grid.411276.7) (ISNI:0000 0001 0725 8811)
13 University of Chicago, Department of Public Health Sciences, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
14 The Francis Crick Institute, London NW1 1AT, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830)
15 The Francis Crick Institute, London NW1 1AT, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830) ; University of Leuven, Department of Human Genetics, Leuven 3000, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884)
16 University of Ibadan, Centre for Population and Reproductive Health, College of Medicine, Ibadan, Nigeria (GRID:grid.9582.6) (ISNI:0000 0004 1794 5983)
17 University of Chicago, Institute for Genomics and Systems Biology, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822) ; Tempus Labs, Inc., Chicago, USA (GRID:grid.170205.1)
18 University of Chicago, Center for Clinical Cancer Genetics & Global Health, Department of Medicine, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822) ; University of Chicago, Department of Public Health Sciences, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
19 University of Chicago, Institute for Genomics and Systems Biology, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822) ; University of Chicago, Center for Clinical Cancer Genetics & Global Health, Department of Medicine, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
20 Novartis Institutes for BioMedical Research, Cambridge, USA (GRID:grid.418424.f) (ISNI:0000 0004 0439 2056) ; Girona Biomedical Research Institute (IDIBGI), Girona 17007, Spain (GRID:grid.429182.4)
Publication year
2019
Publication date
Jan 2019
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2167021246
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.